| Patents for C07K 4 - Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof (2,102) |
|---|
| 01/28/2004 | EP1383393A2 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 01/21/2004 | CN1135223C Aryl-substd propanolamine derivate medicine containing them and their use |
| 01/15/2004 | US20040010811 Mixture comprising modulator for cancer activity; anticarcinogenic agents; tumor diagnosis; immunotherapy |
| 01/08/2004 | US20040006022 For therapy of autoimmune or an inflammatory disease |
| 01/02/2004 | EP1015495B1 Peptide sequences as hinge regions in proteins like immunoglobulin fragments and their use in medicine |
| 01/01/2004 | US20040003418 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer |
| 12/25/2003 | US20030235592 Moraxella catarrhalis protein, gene sequence and uses thereof |
| 12/18/2003 | WO2003082019A3 Peptides with anti-hypertensive properties |
| 12/17/2003 | EP1370298A1 Elongated and multiple spacers in activatible prodrugs |
| 12/16/2003 | US6664370 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
| 12/11/2003 | WO2003037266A3 Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity |
| 12/11/2003 | WO2003037172A9 Endothelial-cell binding peptides for diagnosis and therapy |
| 12/11/2003 | WO2003002730A3 Method for detecting calpain 3 activity in a biological sample and peptides for implementing said method |
| 12/11/2003 | US20030229904 Comprises polypeptide for diagnosis, treatment and prevention of tumors |
| 11/20/2003 | WO2002070703A8 Cell visual characteristic-modifying sequences |
| 11/04/2003 | US6642356 Of given amino acid sequence; non-immunogenic; Fab fragment coupled to effector or reporter molecules; generates dimers which are resistant to chemical reduction |
| 10/23/2003 | WO2003087400A1 Methods and reagents for assaying protein kinase activity |
| 10/23/2003 | CA2481895A1 Methods and reagents for assaying protein kinase activity |
| 10/16/2003 | WO2003085122A2 Endophytic streptomycetes from higher plants with biological activity |
| 10/16/2003 | WO2003012127A3 Assay for identifying inhibitors of hiv rt dimerization |
| 10/16/2003 | US20030195145 Methods of treatment with combinations of statin and aryl-substituted propanolamine derivatives |
| 10/09/2003 | WO2003082197A2 Immunosuppressant compounds, methods and uses related thereto |
| 10/09/2003 | WO2003082019A2 Peptides with anti-hypertensive properties |
| 10/09/2003 | CA2479939A1 Immunosuppressant compounds, methods and uses related thereto |
| 09/24/2003 | EP1049709B1 Antimicrobial peptides |
| 09/18/2003 | US20030176670 Multivalent macrolide antibiotics |
| 09/17/2003 | EP1159295B1 Method of purifying whey of lactic acid fermentation by electrodialysis |
| 09/11/2003 | US20030171274 Antimicrobial proteins |
| 09/04/2003 | WO2002070703A3 Cell visual characteristic-modifying sequences |
| 09/04/2003 | US20030166004 Comprises synthetic or genetically engineered peptide or polypeptide which comprises endothelial cell binding peptides (ECBP) for inhibit angiogenesis and related diseases such as cancer, arthritis and vision defects |
| 09/03/2003 | EP1339837A2 Prolyl endoprotease from aspergillus niger |
| 08/21/2003 | WO2003059385A3 Hiv vaccine and method of use |
| 08/21/2003 | WO2003006070A3 Improved chelator conjugates |
| 07/29/2003 | US6599728 Tankyrase II interacts with telomere-associated proteins, thereby affecting telomerase activity and potentially telomere length |
| 07/24/2003 | WO2003059385A2 Hiv vaccine and method of use |
| 07/24/2003 | CA2472579A1 Hiv vaccine and method of use |
| 07/17/2003 | WO2002083928A3 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer |
| 06/24/2003 | CA2171544C Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains |
| 06/17/2003 | US6579691 DNA sequence encoding a neuronal protein kinase (NPK) which phosphorylates tau proteins as well as other microtubule associated proteins (MAPs) in positions crucial for the binding to microtubules, alzheimers disease, antitumor |
| 06/10/2003 | US6576417 Synthetic antigens for the detection of antibodies to hepatitis C virus |
| 06/05/2003 | US20030104516 Protein kinase npk-110 |
| 05/27/2003 | US6569835 Hypolipidemics; treating obesity and disorders of lipid metabolism |
| 05/20/2003 | US6566509 Compound for use as bactericide |
| 05/20/2003 | US6566340 Aryl-substituted propanolamine derivatives, their preparation, pharmaceuticals comprising them, and their use |
| 05/15/2003 | US20030091586 Fish immunoglobulin |
| 05/14/2003 | EP1309622A2 Lat peptides and their use in assays for identifying immunosuppressants |
| 05/08/2003 | WO2003037266A2 Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity |
| 05/08/2003 | WO2003037172A2 Endothelial-cell binding peptides for diagnosis and therapy |
| 05/08/2003 | US20030087379 Measurement of dimerization of viral polymerase; obtain sample containing viral dimerized proteins, incubate with binding agent, determine the amount of complex formed |
| 05/08/2003 | US20030087306 Methods for identifying novel multimeric agents that modulate receptors |
| 05/08/2003 | CA2466152A1 Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity |
| 05/01/2003 | WO2003035675A1 Biologically active peptides and their use for repairing injured nerves |
| 04/29/2003 | US6555112 Peptides derived from the lymphadenopathy-associated virus (LAV) envelope coding region |
| 04/24/2003 | US20030077267 Purified forms of DNase |
| 04/17/2003 | WO2003031623A1 Cocoa flavour precursor peptides |
| 04/17/2003 | WO1998004278A3 Tetrapeptide derivatives of dolastatin as antitumor agents |
| 04/15/2003 | CA2059979C Complex containing coagulation factor ix |
| 04/02/2003 | EP1298210A1 Cocoa flavour precursor peptides |
| 04/01/2003 | US6541669 Multibinding amine compounds which are beta 2 adrenergic receptor agonists useful in treatment and prevention of respiratory diseases such as asthma, bronchitis |
| 04/01/2003 | US6541616 Exterior membrane; nucleotide sequence; induction immunology response |
| 03/13/2003 | WO2003020749A2 Ncam binding compounds |
| 03/13/2003 | US20030049685 Synthetic antigens for the detection of antibodies to hepatitis C virus |
| 03/13/2003 | CA2459937A1 Ncam binding compounds |
| 03/11/2003 | US6531446 Peptides having biological activity |
| 02/13/2003 | WO2003012127A2 Assay for identifying inhibitors of hiv rt dimerization |
| 02/13/2003 | US20030032769 Second mammalian tankyrase |
| 02/12/2003 | CN1396175A Process for extracting both active embryonic peptide and natural corn oil from embryo bud of corn |
| 02/06/2003 | US20030027980 Process for preparing lipid ii |
| 01/30/2003 | WO2002045523A3 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 01/23/2003 | WO2003006070A2 Improved chelator conjugates |
| 01/22/2003 | EP1276746A2 Process for preparing lipid ii and derivatives thereof |
| 01/22/2003 | CN1392155A Desalting and concentrating of oligopeptide solution by nano filtering technology |
| 01/21/2003 | US6509446 Recombinant genetic information (DNA or RNA), consisting a Chicken Anemia Virus (CAV)-specific nucleotide sequence, useful for diagonestics, vaccination or protein production |
| 01/14/2003 | US6506732 Utilization of whey protein hydrolysate as the active ingredient in skin care composition |
| 01/09/2003 | WO2003002730A2 Method for detecting calpain 3 activity in a biological sample and peptides for implementing said method |
| 01/09/2003 | CA2429429A1 Method for detecting calpain 3 activity in a biological sample and peptides for implementing said method |
| 01/02/2003 | EP1267909A1 Methods of blocking tissue destruction by autoreactive t cells |
| 01/01/2003 | CN1097468C Products containing G-CSF and TNF binding protein |
| 12/31/2002 | US6500431 Inhibitors of angiogenesis and tumor growth |
| 12/11/2002 | EP0591431B1 Hepatitis c virus (hcv) polypeptides |
| 12/05/2002 | US20020183508 Sequences of hepatitis C virus genotypes and their use as prophylactic, therapeutic and diagnostic agents |
| 11/28/2002 | US20020177610 Hypolipidemics; treating obesity and disorders of lipid metabolism |
| 11/28/2002 | US20020177177 Interaction between cyclin D1 and steroid receptor co-activators and uses thereof in assays |
| 11/19/2002 | US6482800 Methods to stimulate angiogenesis |
| 11/14/2002 | US20020168392 Antimicrobial proteins |
| 10/24/2002 | WO2002083928A2 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer |
| 10/24/2002 | WO2002083917A2 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer |
| 10/24/2002 | WO2002083916A2 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |
| 10/24/2002 | WO2002083180A1 Elongated and multiple spacers in activatible prodrugs |
| 10/24/2002 | WO2002045524A3 Prolyl endoprotease from aspergillus niger |
| 10/24/2002 | CA2443141A1 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |
| 10/22/2002 | CA2216601C Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies |
| 09/25/2002 | EP1243276A1 Elongated and multiple spacers containing activatible prodrugs |
| 09/17/2002 | US6451971 Polypeptide cell adhesion inhibitors; antimetastasis and anticarcinogenic agents |
| 09/12/2002 | WO2002070703A2 Cell visual characteristic-modifying sequences |
| 09/12/2002 | CA2439986A1 Cell visual characteristic-modifying sequences |
| 09/04/2002 | EP0904095B1 Chimeric isoprenoid synthases and uses thereof |
| 08/29/2002 | WO1999064055A9 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors |
| 08/27/2002 | US6440412 Purified forms of DNase |
| 08/14/2002 | EP0748335B1 Antibiotic stalobacins |